Clinical Oncology 2020: Management of toxicities from Immunotherapy in cancer patients - Dr R Batool, CT2 - Dr S Basu - Oncology Consultant, Frimley Park Hospital, NHS, United Kingdom
Background: Monoclonal antibodies targeting cytotoxic T lymphocyte-associated antigen 4 (CTLA4) and

